SLGC on NASDAQ

SomaLogic

Logo: SomaLogic, Public domain, via Wikimedia Commons3

American clinical diagnostics company

SomaLogic, Inc. is a protein biomarker discovery and clinical diagnostics company located in Boulder, Colorado.2 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 19, 2026.

Overview

2000Founded1

Compare with another stock.

See how the biggest companies compare on our leaderboards

SomaLogic, Inc. is a protein biomarker discovery and clinical diagnostics company located in Boulder, Colorado. It became listed on Nasdaq in September 2021 with a merger with the special-purpose acquisition company CM Life Sciences II, Inc. The company merged with Standard BioTools in January 2024 and was later acquired by Illumina on January 30, 2026.2

The story

SomaLogic was founded in 2000 by Larry Gold, who served as both Chairman of the Board of Directors and as the company’s first CEO. In 2013, Byron Hewett was appointed as CEO, with Gold continuing to serve as Chairman. Gold previously founded the pharmaceutical company NeXstar Pharmaceuticals, which merged with Gilead in 1999. Hewett stepped down in 2017 and board member Alister Reynolds was appointed the new CEO. A year later, Reynolds was replaced by Roy Smythe.

In July 2022, SomaLogic agreed to acquire Palamedrix Inc, DNA nanotechnology company.

From Wikipedia’s article on SomaLogic, shared under CC BY-SA 4.0.4

Subsidiaries and ownership

Owners

From Wikidata.1

Timeline

  1. 2000Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4